Summit Wealth Group »

Esperion Therapeutics shares owned by Summit Wealth Group

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Summit Wealth Group from 13F filings

Historical chart of Summit Wealth Group investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by Summit Wealth Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by Summit Wealth Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $66k 40k 1.65

More positions owned by Summit Wealth Group

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Msci Usa Mmentm (MTUM)
Vanguard Index Fds Extend Mkt Etf (VXF)
2023 Etf Series Trust Eagle Capital Se (EAGL)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Ishares Tr Core Us Aggbd Et (AGG)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Ishares Tr Global Tech Etf (IXN)
Schwab Strategic Tr Us Tips Etf (SCHP)
Vanguard World Health Car Etf (VHT)
Apple (AAPL)

View all positions for Summit Wealth Group

Top funds holding Esperion Therapeutics

Daniel D. Thurber
BlackRock
BlackRock
Vanguard Group
Bellevue Group
Two Seas Capital
Geode Capital Management
Two Sigma Investments
Two Sigma Advisers
Meditor
State Street Corporation
Morgan Stanley
CenterBook Partners
Marshall Wace
Nuveen Asset Management

View all funds holding Esperion Therapeutics